Rankings
▼
Calendar
LNTH FY 2025 Earnings — Lantheus Holdings, Inc. Revenue & Financial Results | Market Cap Arena
LNTH
Lantheus Holdings, Inc.
$6B
FY 2025 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$1.5B
+0.5% YoY
Gross Profit
$942M
61.1% margin
Operating Income
$311M
20.2% margin
Net Income
$234M
15.2% margin
EPS (Diluted)
$3.41
Cash Flow
Operating Cash Flow
$390M
Free Cash Flow
$354M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$2.2B
Total Liabilities
$1.1B
Stockholders' Equity
$1.1B
Cash & Equivalents
$359M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.5B
$1.5B
+0.5%
Gross Profit
$942M
$988M
-4.7%
Operating Income
$311M
$457M
-32.0%
Net Income
$234M
$312M
-25.2%
← Q4 2024
All Quarters
Q1 2025 →